Literature DB >> 12085329

Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection.

Mathias Lichterfeld1, Ludger Leifeld, Hans Dieter Nischalke, Jürgen K Rockstroh, Lothar Hess, Tilman Sauerbruch, Ulrich Spengler.   

Abstract

T cell recruitment to the infected liver is an essential step for the efficient elimination of hepatitis viruses. The surface expression of CC chemokine receptor (CCR) 1, CCR4, and CCR5 on peripheral blood T lymphocytes and their responsiveness to the chemokines macrophage inflammatory proteins (MIP)-1alpha, MIP-1beta, and RANTES (regulated on activation, normally T cell-expressed and secreted) was analyzed in patients with chronic hepatitis C and hepatitis B infection and compared with healthy subjects. Although CCR4 surface expression was not altered, hepatitis C virus (HCV)-infected patients had lower proportions of CD8 T cells with CCR1 and CCR5 surface expression (P<.05). Migration of CD8 T cells in response to MIP-1alpha, MIP-1beta, and RANTES was significantly reduced in HCV-infected patients (P<.05). Intracellular CCR1 and CCR5 protein and messenger RNA levels in peripheral blood T cells did not indicate reduced chemokine receptor biosynthesis in hepatitis C infection. Thus, chronic hepatitis C, but not hepatitis B, infection alters surface expression of distinct CCRs, resulting in lower CC chemokine responsiveness.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12085329     DOI: 10.1086/340829

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

Review 1.  The role of chemokines in the recruitment of lymphocytes to the liver.

Authors:  Ye H Oo; Shishir Shetty; David H Adams
Journal:  Dig Dis       Date:  2010-05-07       Impact factor: 2.404

2.  Distribution and effects of polymorphic RANTES gene alleles in HIV/HCV coinfection -- a prospective cross-sectional study.

Authors:  Golo Ahlenstiel; Agathe Iwan; Jacob Nattermann; Karin Bueren; Jurgen K Rockstroh; Hans H Brackmann; Bernd Kupfer; Olfert Landt; Amnon Peled; Tilman Sauerbruch; Ulrich Spengler; Rainer P Woitas
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

3.  Functional expression of chemokine receptor CCR5 on CD4(+) T cells during virus-induced central nervous system disease.

Authors:  William G Glass; Thomas E Lane
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

4.  CCR5Delta32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C.

Authors:  Ankur Goyal; P V Suneetha; G T Kumar; Deepak K Shukla; Naveen Arora; Shiv K Sarin
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

Review 5.  The role of chemokines in acute and chronic hepatitis C infection.

Authors:  Stephen Fahey; Eugene Dempsey; Aideen Long
Journal:  Cell Mol Immunol       Date:  2013-08-19       Impact factor: 11.530

6.  Expanded numbers of circulating myeloid dendritic cells in patent human filarial infection reflect lower CCR1 expression.

Authors:  Roshanak Tolouei Semnani; Lily Mahapatra; Benoit Dembele; Siaka Konate; Simon Metenou; Housseini Dolo; Michel E Coulibaly; Lamine Soumaoro; Siaka Y Coulibaly; Dramane Sanogo; Salif Seriba Doumbia; Abdallah A Diallo; Sekou F Traoré; Amy Klion; Thomas B Nutman; Siddhartha Mahanty
Journal:  J Immunol       Date:  2010-10-18       Impact factor: 5.422

7.  CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia.

Authors:  Hermann E Wasmuth; Alexa Werth; Tobias Mueller; Thomas Berg; Christoph G Dietrich; Andreas Geier; Ramin Schirin-Sokhan; Carsten Gartung; Johann Lorenzen; Siegfried Matern; Frank Lammert
Journal:  J Mol Med (Berl)       Date:  2003-12-13       Impact factor: 4.599

Review 8.  Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection.

Authors:  Juan R Larrubia; Selma Benito-Martínez; Miryam Calvino; Eduardo Sanz-de-Villalobos; Trinidad Parra-Cid
Journal:  World J Gastroenterol       Date:  2008-12-21       Impact factor: 5.742

9.  HCV peptide (C5A), an amphipathic α-helical peptide of hepatitis virus C, is an activator of N-formyl peptide receptor in human phagocytes.

Authors:  Qing Lin; Dan Fang; Xinwei Hou; Yingying Le; Jiazhu Fang; Feng Wen; Wanghua Gong; Keqiang Chen; Ji Ming Wang; Shao Bo Su
Journal:  J Immunol       Date:  2011-01-12       Impact factor: 5.422

10.  Restored circulating invariant NKT cells are associated with viral control in patients with chronic hepatitis B.

Authors:  Xiaotao Jiang; Mingxia Zhang; Qintao Lai; Xuan Huang; Yongyin Li; Jian Sun; William G H Abbott; Shiwu Ma; Jinlin Hou
Journal:  PLoS One       Date:  2011-12-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.